SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291650.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
1 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291649d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
2 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291649c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
3 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291649.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
4 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291647d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
5 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291648c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
6 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291648.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
7 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291647c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
8 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291647.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
9 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291648d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
10 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291650c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
11 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291643c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
12 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291651.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
13 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291651c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
14 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291651d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
15 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291652.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
16 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291652c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
17 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291652d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
18 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291653.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
19 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291653c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
20 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291653d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
21 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291646d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
22 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291650d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
23 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291646c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
24 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291641.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
25 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291645d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
26 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291638.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
27 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291638c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
28 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291638d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
29 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291639.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
30 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291639c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
31 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291639d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
32 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291640.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
33 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291646.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
34 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291640d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
35 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291641c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
36 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291641d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
37 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291640c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
38 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291642c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
39 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291642.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
40 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291645.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
41 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291644d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
42 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291644c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
43 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291645c.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
44 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291643d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
45 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291643.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
46 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291642d.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
47 |
SYSMHC00006 |
SYSMHC00006_hassanc_160817_vanveelen_netherlands_HHC_SCX |
SYSMHC00006_s291644.RAW |
Human |
In vitro |
Blood |
Lymphoblast cell |
suspension |
|
HHC SCX |
class I |
HLA-A02:01,HLA-B07:02,HLA-B44:02,HLA-C05:01,HLA-C07:02 |
23481700 |
native |
Immunoaffinity |
W6/32 |
LTQ-FT |
Agilent 1100 plus flowsplitter |
no |
DDA |
CID |
0-50%B |
120 |
5 um id 15 cm |
48 |